Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-16

FDA Approved: APONVIE — Original Application (Heron Therapeutics, Inc.)

View source ↗

Summary

The FDA approved APONVIE, an intravenous formulation of aprepitant from Heron Therapeutics, under an original drug application for the prevention of chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APONVIE (APREPITANT)

Snippet

ORIG AP for APONVIE (APREPITANT)